CMND SCHEDULE 13G/A: SEC filing

Iroquois Capital Management, LLC and associated reporting persons

Filed with the SEC on · accession 0000930413-26-003346

CMND filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Iroquois Capital Management, LLC and associated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of warrants to purchase up to 650,000 common shares of Clearmind Medicine Inc., subject to 9.99% and 4.99% exercise blockers, representing 9.99% of the outstanding shares… The stock moved -4.5% by the first close after the filing.

Summary of the filing

Iroquois Capital Management, LLC and associated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of warrants to purchase up to 650,000 common shares of Clearmind Medicine Inc., subject to 9.99% and 4.99% exercise blockers, representing 9.99% of the outstanding shares on an as-exercised basis.

Key details

Warrants to purchase common shares held by Iroquois Master Fund$335K
Warrants to purchase common shares held by ICIG$315K
Total warrants to purchase common shares reported by Richard Abbe$650K
IssuerClearmind Medicine Inc.
Reporting person / investment advisorIroquois Capital Management, LLC
Holder of warrants to purchase 335,000 common sharesIroquois Master Fund Ltd.
Holder of warrants to purchase 315,000 common sharesIroquois Capital Investment Group LLC
President of iroquois capital management, llcRichard Abbe
Director of iroquois master fundKimberly Page

How CMND stock reacted

Close before

$4.44

Nov 13, 2026

First close after

-4.50%

$4.24

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CMND, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CMND?

Click here

Frequently asked questions

What did CMND file with the SEC on Nov 16, 2026?

CMND filed a SCHEDULE 13G/A (SEC filing). Iroquois Capital Management, LLC and associated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of warrants to purchase up to 650,000 common shares of Clearmind Medicine Inc., subject to 9.99% and 4.99% exercise blockers, representing 9.99% of the outstanding shares on an as-exercised basis.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did CMND stock react to this filing?

CMND closed at $4.44 before the filing and $4.24 on Nov 16, 2026 (-4.50%).

Other CMND SEC filings

Get alerts when CMND files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days